Sikora K - Search Results

1

Establishment and in vivo characterization of multidrug-resistant dunning R3327 rat prostate-carcinoma cell-lines.

Bashir I, Sikora K, Abel P, Foster CS. Bashir I, et al. Among authors: sikora k. Int J Cancer. 1994 Jun 1;57(5):719-26. doi: 10.1002/ijc.2910570519. Int J Cancer. 1994. PMID: 7910810

2

Multidrug resistance and behavioural phenotype of cancer cells.

Bashir I, Sikora K, Foster CS. Bashir I, et al. Among authors: sikora k. Cell Biol Int. 1993 Oct;17(10):907-17. doi: 10.1006/cbir.1993.1013. Cell Biol Int. 1993. PMID: 8287021 Review.

3

Cell-surface oligosaccharides expressed by phenotypically distinct sublines of the Dunning 3327 rat prostate cancer.

Bashir I, Sikora K, Foster CS. Bashir I, et al. Among authors: sikora k. Biochem Soc Trans. 1990 Oct;18(5):968-9. doi: 10.1042/bst0180968. Biochem Soc Trans. 1990. PMID: 2083773 No abstract available.

4

Cell-cycle expression of prostatic tumour oligosaccharides analysed using dual-parameter flow cytometry.

Palmeiro E, Sikora K, Foster CS. Palmeiro E, et al. Among authors: sikora k. Biochem Soc Trans. 1990 Dec;18(6):1285-7. doi: 10.1042/bst0181285. Biochem Soc Trans. 1990. PMID: 2088923 No abstract available.

5

Generation of a monoclonal antibody to P-glycoprotein peptides using tuberculin-PPD as a carrier.

Bashir I, Sikora K, Foster CS. Bashir I, et al. Among authors: sikora k. Virchows Arch. 1998 Mar;432(3):279-87. doi: 10.1007/s004280050166. Virchows Arch. 1998. PMID: 9532008

6

Oncogene expression in cholangiocarcinoma and in normal hepatic development.

Voravud N, Foster CS, Gilbertson JA, Sikora K, Waxman J. Voravud N, et al. Among authors: sikora k. Hum Pathol. 1989 Dec;20(12):1163-8. doi: 10.1016/s0046-8177(89)80006-1. Hum Pathol. 1989. PMID: 2574140

7

Two-monthly depot gonadotropin releasing hormone agonist (buserelin) for treatment of prostatic cancer.

Waxman JH, Sandow J, Abel P, Farah N, O'Donoghue EP, Fleming J, Cox J, Sikora K, Williams G. Waxman JH, et al. Among authors: sikora k. Acta Endocrinol (Copenh). 1989 Mar;120(3):315-8. doi: 10.1530/acta.0.1200315. Acta Endocrinol (Copenh). 1989. PMID: 2494825 Clinical Trial.

8

The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.

Waxman J, Williams G, Sandow J, Hewitt G, Abel P, Farah N, Fleming J, Cox J, O'Donoghue EP, Sikora K. Waxman J, et al. Among authors: sikora k. Am J Clin Oncol. 1988;11 Suppl 2:S152-5. doi: 10.1097/00000421-198801102-00036. Am J Clin Oncol. 1988. PMID: 2853934 Clinical Trial.

9

New combination chemotherapy programme for bladder cancer.

Waxman J, Abel P, James N, Farah N, O'Donoghue EP, Mee D, Colbeck R, Sikora K, Williams G. Waxman J, et al. Among authors: sikora k. Br J Urol. 1989 Jan;63(1):68-71. doi: 10.1111/j.1464-410x.1989.tb05126.x. Br J Urol. 1989. PMID: 2920263

10

Bladder cancer: inter-relationships between chemotherapy and radiotherapy.

Waxman J, Barton C, Biruls R, James N, Harrison M, Rogers H, Mee D, Sikora K, Colbeck R, Abel P, et al. Waxman J, et al. Among authors: sikora k. Br J Urol. 1992 Feb;69(2):151-5. doi: 10.1111/j.1464-410x.1992.tb15487.x. Br J Urol. 1992. PMID: 1537027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

420 results

Search Page

Filters